|
|
Dear Alexandros Sfakianakis, We are pleased to deliver your requested table of contents alert for Drug Safety. Volume 39 Number 5 is now available online. | | |
In this issue |
Measuring Signal Detection Performance: Can We Trust Negative Controls and Do We Need Them? Jim Slattery | |
|
Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients Sheriza N. Baksh, Walid F. Gellad & G. Caleb Alexander | |
|
Side Effects and Efficacy of Neuraxial Opioids in Pregnant Patients at Delivery: A Comprehensive Review Sarah Armstrong & Roshan Fernando | |
|
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases Annamaria Mascolo, Concetta Rafaniello, Liberata Sportiello, Maurizio Sessa, Daniela Cimmaruta, Francesco Rossi & Annalisa Capuano | |
|
Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants Haixia Li, Cailian Wang, Shuo Zhang, Sihao Sun, Ruifei Li, Meijuan Zou & Gang Cheng | |
|
Original Research Article | | Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP) Manfred Hauben, Jeffrey K. Aronson & Robin E. Ferner | |
|
Original Research Article | | An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval Tal Lorberbaum, Kevin J. Sampson, Raymond L. Woosley, Robert S. Kass & Nicholas P. Tatonetti | |
|
Original Research Article | | Social Media Listening for Routine Post-Marketing Safety Surveillance Gregory E. Powell, Harry A. Seifert, Tjark Reblin, Phil J. Burstein, James Blowers, J. Alan Menius, Jeffery L. Painter, Michele Thomas, Carrie E. Pierce, Harold W. Rodriguez, John S. Brownstein, Clark C. Freifeld, Heidi G. Bell & Nabarun Dasgupta | |
|
Original Research Article | | Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase® Jitka Pokladnikova, Ronald H. B. Meyboom, Ricarda Meincke, David Niedrig & Stefan Russmann | |
|
Comment on: "Drug-Induced Hyperglycaemia and Diabetes" Jean-Louis Montastruc, Leila Chebane & Haleh Bagheri | |
|
Authors' Reply to Montastruc et al.: "Drug-Induced Hyperglycaemia and Diabetes" Neila Fathallah, Raoudha Slim, Sofiene Larif, Houssem Hmouda & Chaker Ben Salem | |
|
| | Do you want to publish your article in this journal? Please visit the homepage of Drug Safety for full details on: - aims and scope
- editorial policy
- article submission
Impact Factor: 2.824 (2014) Journal Citation Reports®, Thomson Reuters | | | |
| | Read open access articles Click here to view all open access articles published in this journal.
Interested in publishing your article open access? When you opt for Open Choice, you retain full copyright and your article is permanently freely available. | | | |
| | Sign up for SpringerAlerts! Register for Springer's email services providing you with info on the latest books in your field. » Click here | | | |
|
This email has been sent to alsfakia.journals2@blogger.com
You are receiving this email because you have opted to receive information from SpringerAlerts as a registered user of our Table of Content Alert for journals.
To ensure the delivery to your inbox, please add the sender address springer@alerts.springer.com to your allow list.
To modify your subscription (including change of email address etc.), please go to http://ift.tt/Lqiruf and log in with your email address and password.
To unsubscribe from this specific table of contents alert, please click here. To unsubscribe from ALL table of contents alerts, please click here.
For all enquiries, problems or suggestions regarding this service, please contact onlineservice@springer.com.
Springer respects your privacy and does not disclose, sell or rent your personal information to any nonaffiliated third parties without your consent. Please visit the Springer Privacy Statement.
Springer-Verlag GmbH Heidelberg, Tiergartenstrasse 17, 69121 Heidelberg, Germany, phone: +49 6221 487 0, fax: +49 6221 487 8366
© Springer 2016, springer.com |
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου